Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
BioVentrix logo — company profile

BioVentrix

Founded 2003 United States San Ramon, United States 17 employees Series A Total: $230.16M Biotechnology, Health Care +1

General Information

Company Name BioVentrix
Founded Year 2003
Location United States San Ramon, United States
Founders / Decision Makers
Team member
Employees 17
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with BioVentrix. To contact BioVentrix, visit bioventrix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioVentrix compare?

A PDF of BioVentrix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioVentrix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioVentrix

BioVentrix is a biotechnology startup founded in 2003 and headquartered in San Ramon, CA, USA. The company focuses on improving and expanding the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy through less invasive, catheter-based approaches. In the latest funding round, BioVentrix secured a substantial $48.50M Series A investment on April 13, 2023 from an impressive consortium of investors including Cormorant Asset Management, Squarepoint Capital, Taglich Brothers, Richmond Brothers, Inc., and Andera Partners. BioVentrix's mission resonates with the growing need for innovative solutions in the health care industry, particularly in addressing the challenges of heart failure. The company's offerings present significant benefits to various stakeholders within the heart failure ecosystem, including patients, payors, and healthcare providers. By targeting the underlying cause of heart failure with less invasive interventions, BioVentrix aims to contribute to improved survival rates and quality of life for patients, while also reducing hospitalizations and steering clear of more expensive and invasive procedures like transplants and LVADs. With its focus on biotechnology and healthcare, BioVentrix operates in critical and rapidly evolving segments of the medical field. The company's ability to attract a substantial Series A investment from reputable backers underscores the confidence that major investment firms have in the potential of its innovative solutions. This significant injection of capital positions BioVentrix for further advancement in its mission to revolutionize the treatment of congestive heart failure, making it a notable player in the biotechnology and healthcare industries.

Business keywords: Medical device, Congestive heart failure, Ischemic cardiomyopathy, Less invasive treatment, Catheter-based approach, Cardiology, Heart disease, Innovation, Patient care, Health technology, Medical innovation

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $48.50M 5
Andera Partner Squarepoint Capital Cormorant Asset Management
Andera Partner, Squarepoint Capital +3
13 Apr 2023
Venture Round $1.00M -
05 Apr 2022
Venture Round $5.98M -
10 Jan 2022
Venture Round $40.76M -
22 Dec 2020
Venture Round $21.78M -
01 May 2019
Venture Round $40.00M -
25 Aug 2017
Convertible Note $14.50M -
03 Jul 2017
Venture Round $14.00M -
08 Dec 2015
Venture Round $14.00M -
12 Dec 2014
Venture Round $12.43M -
24 Jan 2014

View All 14 Funding Rounds

BioVentrix Alternatives & Competitors

View All Alternatives
BioVentrix vs
InterShunt Technologies, Inc.
InterShunt Technologies, Inc. United States

Heart Failure is one of the most debilitating medical issues we face. It is the leading cause of hos...

Non Equity Assistance
7 employees
Biotechnology, Health Care
BioVentrix vs
Puzzle Medical Devices Inc.
Puzzle Medical Devices Inc. Canada

Presenting the ModulHeart. Low-risk heart support for patients with advanced heart failure

Series A
32 employees
Health Care, Medical Devices
BioVentrix vs
Procyrion, Inc.
Procyrion, Inc. United States

Developing catheter-based circulatory support devices to address the needs of heart failure and kidn...

Series E
28 employees
Health Care, Medical Devices
Also compare with: BioVentrix vs Impulse Dynamics Impulse Dynamics View all alternatives

FAQ About BioVentrix

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches. BioVentr...
BioVentrix was founded in 2003.
BioVentrix is headquartered in San Ramon, United States.
BioVentrix operates in Biotechnology, Health Care and Medical Devices. Its work centres on Medical device, Congestive heart failure, Ischemic cardiomyopathy and Less invasive treatment.
BioVentrix has approximately 17 employees.
BioVentrix has completed 14 funding rounds, raising a total of $230.16M. The latest funding stage is Series A.
Top alternatives and competitors to BioVentrix include InterShunt Technologies, Inc., Puzzle Medical Devices Inc., Procyrion, Inc., Remon Medical Technologies, Pi-Cardia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioVentrix and InterShunt Technologies, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioVentrix, https://bouncewatch.com/company/bioventrix, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes